Syngene International
SYNGENE · Pharma > Pharmaceuticals & Drugs · Chairman: Kiran Mazumdar Shaw · MD: Jonathan Hunt · Listing date: Aug. 11, 2015 · Employees: 5437 · Bangalore · http://www.syngeneintl.com

Stock Price vs Company Growth
1d
1.3%
1w
14.2%
1m
14.4%
3m
16.4%
6m
28.7%
1y
10.8%
5y
15.1%
all
15.5%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowMar15Mar17Mar19Mar21Mar23Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

622 1.3%
616
770
Company Overview

Sales
3,642 Cr
Growth: 4.6%
Profit after Tax
464 Cr
Growth: -1.1%
Mid Cap
25,049 Cr
P/E: 50.3x
Industry P/E: 32.0x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 3,642
Growth 4.6%
EBITDA 28.4%
P/S 6.9x
Dividend 0.2%
P/E 50.3x
Book Value ₹ 117
PEG Ratio 10.9x
ROE 10.3%
P/B 5.3x
Shareholding Pattern

Institutions
Government Pension Fund Global
1.14 %
Uti-Mid Cap Fund
1.03 %
Qualified Institutional Buyer
0.15 %
Created with Highcharts 8.2.2Mar20Jun20Sep20Dec20Mar21Jun21Sep21Dec21Mar22Jun22Mar23Sep23Dec23Mar24Jun24Sep24Dec24Mar25
Promoters
Biocon Limited
70.1 %
Biocon Limited Employee Welfare Trust (Murali Krishnan K N And Amitava Saha)
0.32 %
Yamini R Mazumdar
0.01 %
Created with Highcharts 8.2.2Mar20Jun20Sep20Dec20Mar21Jun21Sep21Dec21Mar22Jun22Mar23Sep23Dec23Mar24Jun24Sep24Dec24Mar25
Others
Created with Highcharts 8.2.2Mar20Jun20Sep20Dec20Mar21Jun21Sep21Dec21Mar22Jun22Mar23Sep23Dec23Mar24Jun24Sep24Dec24Mar25
Increase    Decrease    No change
Company Profile Detailed

The company is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide.
Investors (435)
Followers (15)